Idera raises $75M in follow-on

Idera Pharmaceuticals Inc. (NASDAQ:IDRA) raised $75 million through the sale of 20

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE